Moderna Stock Price on May 11, 2022 Breakdown

MRNA -  USA Stock  

USD 144.27  1.01  0.70%

As of today, the current price of Moderna is  144.27 , as last reported on the 24th of June, with the highest price reaching  144.89  and the lowest price hitting  138.22  during the day.
Moderna has Sharpe Ratio of -0.0447, which conveys that the firm had -0.0447% of return per unit of risk over the last 3 months. Macroaxis standpoint towards estimating the risk of any stock is to look at both systematic and unsystematic factors of the business, including all available market data and technical indicators. Moderna exposes twenty-one different technical indicators, which can help you to evaluate volatility that cannot be diversified away. Please be advised to verify Moderna mean deviation of 3.73, and Risk Adjusted Performance of (0.09) to check out the risk estimate we provide.
The current year Net Income Common Stock is expected to grow to about 13.2 B. The current year Price to Book Value is expected to grow to 8.49. The current year Price to Earnings Ratio is expected to grow to 9.04. Moderna Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Most Recent Activity

Shares Float
359.9 M
Shares Outstanding
397.8 M
Shares Short Prior Month
17.1 M
Earnings Share
Shares Short
15.5 M
Revenue Per Share

Moderna Main Headline on 11th of May 2022

Filed transaction by Moderna Inc officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Moderna Valuation on May 11, 2022

It is possible to determine the worth of Moderna on a given historical date. On May 11, 2022 Moderna was worth 130.74 at the beginning of the trading date compared to the closed value of 123.43. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Moderna stock. Still, in general, we apply an absolute valuation method to find Moderna's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Visa where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Moderna's related companies.
 Open High Low Close Volume
  137.40    139.06    127.61    132.32    8,133,325  
  130.74    134.91    122.72    123.43    7,359,887  
  120.60    132.94    119.02    130.17    7,011,249  
Backtest Moderna  |  Moderna History  |  Moderna Valuation   PreviousNext  
Open Value 130.74
Closing Value

Moderna Trading Date Momentum on May 11, 2022

On May 12 2022 Moderna was traded for  130.17  at the closing time. The top price for the day was 132.94  and the lowest listed price was  119.02 . The trading volume for the day was 7 M. The trading history from May 12, 2022 was a factor to the next trading day price jump. The trading delta at closing time against the next closing price was 5.46% . The trading delta at closing time against the current closing price is 11.48% .

Moderna Fundamentals Correlations and Trends

By evaluating Moderna's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Moderna's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Moderna financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Moderna Stock history

Moderna investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Moderna is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Moderna will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Moderna historical stock prices may prove useful in developing a viable investing in Moderna
Last ReportedProjected for 2022
Weighted Average Shares403 M339.6 M
Weighted Average Shares Diluted431 M357 M
Issuance Purchase of Equity Shares-733 M-752.3 M
Moderna, Inc., a biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States and internationally. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts. Moderna operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 2700 people.

Moderna Quarterly Market Capitalization

69.4 Billion


Moderna Stock Technical Analysis

Moderna technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Moderna technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Moderna trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Moderna Period Price Range

May 11, 2022





Moderna June 24, 2022 Market Strength

Market strength indicators help investors to evaluate how Moderna stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Moderna shares will generate the highest return on investment. By undertsting and applying Moderna stock market strength indicators, traders can identify Moderna entry and exit signals to maximize returns

Moderna Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Moderna stock's direction in advance. Along with the technical and fundamental analysis of Moderna Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Moderna to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen stock market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Additionally, see Stocks Correlation. Note that the Moderna information on this page should be used as a complementary analysis to other Moderna's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Global Correlations module to find global opportunities by holding instruments from different markets.

Complementary Tools for Moderna Stock analysis

When running Moderna price analysis, check to measure Moderna's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Moderna is operating at the current time. Most of Moderna's value examination focuses on studying past and present price action to predict the probability of Moderna's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Moderna's price. Additionally, you may evaluate how the addition of Moderna to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
CEO Directory
Screen CEOs from public companies around the world
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Is Moderna's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Moderna. If investors know Moderna will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Moderna listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
Market Capitalization
57 B
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of Moderna is measured differently than its book value, which is the value of Moderna that is recorded on the company's balance sheet. Investors also form their own opinion of Moderna's value that differs from its market value or its book value, called intrinsic value, which is Moderna's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Moderna's market value can be influenced by many factors that don't directly affect Moderna's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Moderna's value and its price as these two are different measures arrived at by different means. Investors typically determine Moderna value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Moderna's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.